Geneva, July 14 -- International Clinical Trials Registry received information related to the study (ISRCTN93189645) titled 'Reverse the clock: a clinical trial of collagen activator effects on biological age and skin quality' on July 5.
Study Type: Observational
Study Design:
Single-centre observational cohort study (Safety, Efficacy)
Primary Sponsor: Avea Life AG
Condition:
Efficacy of Collagen supplementation in improving skin quality and reducing the signs of skin aging.
Skin and Connective Tissue Diseases
Intervention:
The study is a human research study in which customers that are taking the collagen activator from Avea are observed for six months. The trial is in the form of a post marketing surveillance observational tria...